Velocell Bio Reviews
Velocell Bio is a new peptide supplier based in the USA.
Take Action
Request Full Data Access to the PeptideScore database of peptide tests.
Products
| Tests | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |||
Retatrutide | BAD | 1 | 3.0 | 3.0 | 3.0 | October 11, 2025 | October 11, 2025 | |||
Semaglutide | BAD | 1 | 3.0 | 3.0 | 3.0 | October 11, 2025 | October 11, 2025 | |||
Tirzepatide | BAD | 1 | 3.0 | 3.0 | 3.0 | October 11, 2025 | October 11, 2025 | |||
NAD+ | BAD | 1 | 3.0 | 3.0 | 3.0 | October 11, 2025 | October 11, 2025 | |||
CJC-1295 | BAD | 1 | 3.0 | 3.0 | 3.0 | October 11, 2025 | October 11, 2025 | |||
BPC-157 | BAD | 1 | 3.0 | 3.0 | 3.0 | October 11, 2025 | October 11, 2025 | |||
About this vendor
Just To Be Clear
This web site is provided for educational and informational purposes only and does not constitute medical advice or professional services. The information provided is not intended to diagnose, treat, cure, or prevent a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. None of the statements on this site have been evaluated by the FDA or any other regulatory authority.
The "Peptide Score" provided on this site reflect the analysis of tests conducted by or on behalf of Finnrick, and do not constitute an endorsement or recommendation by Finnrick.
Peptide testing services are available to US residents only.
PeptideScore is not liable for any actions taken by you based on the information provided on this site. Your usage of the information on this web site is subject to our Terms of Use.
Get news and updates from Peptide score
We respect your privacy and don't sell your email address.
Socialize
